Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Sana Biotechnology, Inc.
Market Cap
$765.30M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$761.37M
Operating Margin
9.00%
TTM Avg
7.11%
3Y Avg
-27.53%
5Y Avg
-16.39%
Market Cap
$776.24M
Operating Margin
-29.28%
TTM Avg
-127.46%
3Y Avg
-26333.62%
5Y Avg
-23986.43%
Market Cap
$777.34M
Operating Margin
-98.21%
TTM Avg
-366.21%
3Y Avg
-21871.64%
5Y Avg
-19485.10%
Market Cap
$753.02M
Operating Margin
-4974.74%
TTM Avg
-2487.37%
3Y Avg
-2487.37%
5Y Avg
-2487.37%
Market Cap
$778.01M
Operating Margin
-3.29%
TTM Avg
-3.29%
3Y Avg
3.10%
5Y Avg
5.72%
Market Cap
$747.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$785.03M
Operating Margin
-0.31%
TTM Avg
6.92%
3Y Avg
0.39%
5Y Avg
2.91%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | $765.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| Mesa Laboratories, Inc. (MLAB)vs › | $761.37M | 9.00% | 7.11% | -27.53% | -16.39% |
| Geron Corporation (GERN)vs › | $776.24M | -29.28% | -127.46% | -26333.62% | -23986.43% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $777.34M | -98.21% | -366.21% | -21871.64% | -19485.10% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $753.02M | -4974.74% | -2487.37% | -2487.37% | -2487.37% |
| Varex Imaging Corporation (VREX)vs › | $778.01M | -3.29% | -3.29% | 3.10% | 5.72% |
| Design Therapeutics, Inc. (DSGN)vs › | $747.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | -0.31% | 6.92% | 0.39% | 2.91% |
| Apnimed, Inc. (APMD)vs › | $742.70M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | 9.86% | 12.61% | -6.26% | -239.99% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
